Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(1):36–39. doi: 10.1038/bjc.1997.332

Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma.

F Bertoni 1, G Bosshard 1, E Roggero 1, E Ceresa 1, F Cavalli 1, E Zucca 1
PMCID: PMC2223780  PMID: 9218729

Abstract

We evaluated the prognostic role of peripheral blood polymerase chain reaction (PCR) assay for detection of the bcl-2(MBR)/J(H) rearrangement in 59 patients with follicular lymphoma (FL) treated at our centre since 1989. Thirty-five (59%) patients were bcl-2/J(H) positive and 24 (41%) were negative in the peripheral blood at diagnosis. Peripheral blood bcl-2/J(H) rearrangement detection at diagnosis had no relation to overall survival (OS) and time to progression (TTP). Peripheral blood PCR assay was performed post treatment in 17 patients who were bcl-2/J(H) positive at diagnosis. Fourteen of the patients (82%, 95% CI 56-96%) became bcl-2/J(H) negative. Nine of these patients were further analysed during follow-up and, after several months, circulating cells carrying the bcl-2/J(H) rearrangement reappeared in five of the nine patients. Peripheral blood clearance of bcl-2/J(H)-positive cells was correlated with better overall survival (log-rank P < 0.05) but not with TTP. Our data confirmed that bcl-2(MBR)/J(H) rearrangement detection by PCR at diagnosis is not a prognostic factor in follicular lymphoma. In our series, clearance of circulating bcl-2/J(H)-positive cells appeared to correlate with better overall survival. Post-treatment examination of the peripheral blood by PCR may have clinical relevance for prediction of the survival pattern of the patients.

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell D. A., Liu Y., Cortopassi G. A. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst. 1995 Feb 1;87(3):223–224. doi: 10.1093/jnci/87.3.223. [DOI] [PubMed] [Google Scholar]
  2. Berinstein N. L., Reis M. D., Ngan B. Y., Sawka C. A., Jamal H. H., Kuzniar B. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma. J Clin Oncol. 1993 Jul;11(7):1344–1352. doi: 10.1200/JCO.1993.11.7.1344. [DOI] [PubMed] [Google Scholar]
  3. Betticher D. C., Zucca E., von Rohr A., Egger T., Radford J. A., Ambrosetti A., Bürki K., Rufener B., Schmitz S. F., Cerny T. 2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma. Ann Oncol. 1996 Oct;7(8):793–799. doi: 10.1093/oxfordjournals.annonc.a010757. [DOI] [PubMed] [Google Scholar]
  4. Corbally N., Grogan L., Dervan P. A., Carney D. N. The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction. Br J Cancer. 1992 Nov;66(5):805–809. doi: 10.1038/bjc.1992.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cotter F. E., Price C., Meerabux J., Zucca E., Young B. D. Direct sequence analysis of 14q+ and 18q- chromosome junctions at the MBR and MCR revealing clustering within the MBR in follicular lymphoma. Ann Oncol. 1991 Feb;2 (Suppl 2):93–97. doi: 10.1007/978-1-4899-7305-4_15. [DOI] [PubMed] [Google Scholar]
  6. Dölken G., Illerhaus G., Hirt C., Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol. 1996 Apr;14(4):1333–1344. doi: 10.1200/JCO.1996.14.4.1333. [DOI] [PubMed] [Google Scholar]
  7. Finke J., Slanina J., Lange W., Dölken G. Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol. 1993 Sep;11(9):1668–1673. doi: 10.1200/JCO.1993.11.9.1668. [DOI] [PubMed] [Google Scholar]
  8. Gribben J. G., Freedman A. s., Woo S. D., Blake K., Shu R. S., Freeman G., Longtine J. A., Pinkus G. S., Nadler L. M. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood. 1991 Dec 15;78(12):3275–3280. [PubMed] [Google Scholar]
  9. Gribben J. G., Neuberg D., Barber M., Moore J., Pesek K. W., Freedman A. S., Nadler L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood. 1994 Jun 15;83(12):3800–3807. [PubMed] [Google Scholar]
  10. Hardingham J. E., Kotasek D., Sage R. E., Gooley L. T., Mi J. X., Dobrovic A., Norman J. E., Bolton A. E., Dale B. M. Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol. 1995 May;13(5):1073–1079. doi: 10.1200/JCO.1995.13.5.1073. [DOI] [PubMed] [Google Scholar]
  11. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  12. Hickish T. F., Purvies H., Mansi J., Soukop M., Cunningham D. Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification. Br J Cancer. 1991 Dec;64(6):1161–1163. doi: 10.1038/bjc.1991.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hockenbery D., Nuñez G., Milliman C., Schreiber R. D., Korsmeyer S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990 Nov 22;348(6299):334–336. doi: 10.1038/348334a0. [DOI] [PubMed] [Google Scholar]
  14. Ji W., Qu G. Z., Ye P., Zhang X. Y., Halabi S., Ehrlich M. Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res. 1995 Jul 1;55(13):2876–2882. [PubMed] [Google Scholar]
  15. Johnson A., Brun A., Dictor M., Rambech E., Akerman M., Anderson H. Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade. A report from southern Sweden. Ann Oncol. 1995 Oct;6(8):789–794. doi: 10.1093/oxfordjournals.annonc.a059317. [DOI] [PubMed] [Google Scholar]
  16. Lambrechts A. C., Hupkes P. E., Dorssers L. C., van't Veer M. B. Clinical significance of t(14; 18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol. 1994 Aug;12(8):1541–1546. doi: 10.1200/JCO.1994.12.8.1541. [DOI] [PubMed] [Google Scholar]
  17. Lambrechts A. C., Hupkes P. E., Dorssers L. C., van't Veer M. B. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood. 1993 Oct 15;82(8):2510–2516. [PubMed] [Google Scholar]
  18. Limpens J., Stad R., Vos C., de Vlaam C., de Jong D., van Ommen G. J., Schuuring E., Kluin P. M. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 1995 May 1;85(9):2528–2536. [PubMed] [Google Scholar]
  19. Liu Y., Hernandez A. M., Shibata D., Cortopassi G. A. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8910–8914. doi: 10.1073/pnas.91.19.8910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mrózek K., Bloomfield C. D. Cytogenetics of indolent lymphomas. Semin Oncol. 1993 Oct;20(5 Suppl 5):47–57. [PubMed] [Google Scholar]
  21. Price C. G., Meerabux J., Murtagh S., Cotter F. E., Rohatiner A. Z., Young B. D., Lister T. A. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol. 1991 Sep;9(9):1527–1532. doi: 10.1200/JCO.1991.9.9.1527. [DOI] [PubMed] [Google Scholar]
  22. Tilly H., Rossi A., Stamatoullas A., Lenormand B., Bigorgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood. 1994 Aug 15;84(4):1043–1049. [PubMed] [Google Scholar]
  23. Weiss L. M., Warnke R. A., Sklar J., Cleary M. L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987 Nov 5;317(19):1185–1189. doi: 10.1056/NEJM198711053171904. [DOI] [PubMed] [Google Scholar]
  24. Whang-Peng J., Knutsen T., Jaffe E. S., Steinberg S. M., Raffeld M., Zhao W. P., Duffey P., Condron K., Yano T., Longo D. L. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood. 1995 Jan 1;85(1):203–216. [PubMed] [Google Scholar]
  25. Yuan R., Dowling P., Zucca E., Diggelmann H., Cavalli F. Detection of bcl-2/JH rearrangement in follicular and diffuse lymphoma: concordant results of peripheral blood and bone marrow analysis at diagnosis. Br J Cancer. 1993 May;67(5):922–925. doi: 10.1038/bjc.1993.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yunis J. J., Frizzera G., Oken M. M., McKenna J., Theologides A., Arnesen M. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med. 1987 Jan 8;316(2):79–84. doi: 10.1056/NEJM198701083160204. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES